Wamberg Genomic Advisers: Robert Green
Wamberg Genomic Advisers has appointed Robert Green to its advisory board. A medical geneticist and physician-scientist, Green directs the G2P Research Program in the Division of Genetics at Brigham and Women's Hospital and Harvard Medical School. He is principal investigator of the MedSeq project, an NIH-funded randomized trial to explore the use of whole-genome sequencing in the clinical practice of medicine, and co-leads the BabySeq project, evaluating sequencing in newborns.
Green also directs the recently established Brigham Preventive Genomics Clinic, which offers comprehensive genome sequencing and interpretation to healthy adults and their children. He was the lead author of the published recommendations from the American College of Medical Genetics and Genomics for management of incidental findings in clinical sequencing. As an advisor to Wamberg, Green will help guide the firm in its further development of product offerings and programs as well as lead the selection of future advisory board members from the scientific community.